Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GSK | London | GBP | Real-time | |
GSKl | BATS Europe | GBP | Delayed | |
GSK | NYSE | USD | Real-time | |
GLAXF | OTC Markets | USD | Delayed | |
GSKN | Mexico | MXN | Delayed | |
GS70y | Frankfurt | EUR | Delayed | |
GS71 | Frankfurt | EUR | Delayed | |
GS71 | TradeGate | EUR | Delayed | |
GS71 | Xetra | EUR | Delayed | |
GSK | Buenos Aires | ARS | Delayed |
GSK plc reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was GBP 7,376 million compared to GBP 7,076 million a year ago. Net income was GBP 1,495 million compared to GBP 749 million a year ago. Basic earnings per share from continuing operations was GBP 0.372 compared to GBP 0.106 a year ago. Diluted earnings per share from continuing operations was GBP 0.366 compared to GBP 0.105 a year ago. Basic earnings per share was GBP 0.371 compared to GBP 0.187 a year ago. Diluted earnings per share was GBP 0.365 compared to GBP 0.185 a year ago.For the full year, sales was GBP 29,324 million compared to GBP 24,696 million a year ago. Net income was GBP 14,956 million compared to GBP 4,385 million a year ago. Basic earnings per share from continuing operations was GBP 1.108 compared to GBP 0.829 a year ago. Diluted earnings per share from continuing operations was GBP 1.092 compared to GBP 0.818 a year ago. Basic earnings per share was GBP 3.714 compared to GBP 1.096 a year ago. Diluted earnings per share was GBP 3.662 compared to GBP 1.082 a year ago.
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Revenue | 7376 | 7829 | 6929 | 7190 |
Gross Profit | 5190 | 5443 | 4784 | 4500 |
Operating Income | 1415 | 2361 | 1709 | 1708 |
Net Income | 2001 | 10315 | 838 | 1802 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Assets | 60146 | 60313 | 89045 | 89689 |
Total Liabilities | 50050 | 51597 | 66405 | 67057 |
Total Equity | 10096 | 8716 | 22640 | 22632 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 1905 | 1321 | 2542 | |
Cash From Investing Activities | -540 | -4094 | -3593 | |
Cash From Financing Activities | -1338 | -1326 | 7973 | |
Net Change in Cash | 73 | -4076 | 6934 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review